13.56
price down icon0.84%   -0.115
 
loading
Schlusskurs vom Vortag:
$13.68
Offen:
$13.57
24-Stunden-Volumen:
186.44K
Relative Volume:
0.61
Marktkapitalisierung:
$453.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-47.20M
KGV:
-8.6661
EPS:
-1.5653
Netto-Cashflow:
$-43.65M
1W Leistung:
+11.23%
1M Leistung:
+22.76%
6M Leistung:
+26.19%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$13.18
$14.20
1-Wochen-Bereich:
Value
$11.56
$14.20
52-Wochen-Spanne:
Value
$4.8069
$27.50

Mbx Biosciences Inc Stock (MBX) Company Profile

Name
Firmenname
Mbx Biosciences Inc
Name
Telefon
(317) 989-3100
Name
Adresse
11711 N. MERIDIAN STREET, CARMEL
Name
Mitarbeiter
43
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MBX's Discussions on Twitter

Vergleichen Sie MBX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MBX
Mbx Biosciences Inc
13.56 391.07M 0 -47.20M -43.65M -1.5653
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
475.19 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.92 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.46 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
589.03 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.53 31.99B 3.81B -644.79M -669.77M -6.24

Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-16 Eingeleitet Oppenheimer Outperform
2025-04-10 Eingeleitet Citizens JMP Mkt Outperform
2024-10-08 Eingeleitet Guggenheim Buy
2024-10-08 Eingeleitet JP Morgan Overweight
2024-10-08 Eingeleitet Jefferies Buy
2024-10-08 Eingeleitet Stifel Buy
Alle ansehen

Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten

pulisher
Jul 23, 2025

Is MBX Biosciences Inc. a good long term investmentExtraordinary market timing - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about MBX Biosciences Inc. stockJaw-dropping returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Oppenheimer reiterates Outperform rating on MBX Biosciences stock ahead of Phase 2 data - Investing.com India

Jul 23, 2025
pulisher
Jul 22, 2025

What drives MBX Biosciences Inc. stock priceHigh-velocity capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why MBX Biosciences Inc. stock attracts strong analyst attentionSmart Growth Low Risk Picks - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

MBX Biosciences Inc. Stock Analysis and ForecastUnmatched market gains - printweek.in

Jul 20, 2025
pulisher
Jul 20, 2025

MBX Biosciences (NYSE:MBX) Coverage Initiated by Analysts at Oppenheimer - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

MBX Biosciences, Inc. (NYSE:MBX) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Oppenheimer - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Is MBX Biosciences Inc. stock a good hedge against inflationLow Risk Stock Strategies - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Is MBX Biosciences Inc. stock overhyped or has real potentialFree Investment Community - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

MBX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Oppenheimer Initiates Coverage on MBX Biosciences with Outperform Rating, PT $38 - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Oppenheimer initiates MBX Biosciences stock with Outperform rating - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

Oppenheimer initiates MBX Biosciences stock with Outperform rating By Investing.com - Investing.com India

Jul 16, 2025
pulisher
Jul 16, 2025

Oppenheimer initiates coverage on MBX Biosciences with 'outperform' - TradingView

Jul 16, 2025
pulisher
Jul 16, 2025

MBX Biosciences stock maintains Market Outperform rating at JMP By Investing.com - Investing.com India

Jul 16, 2025
pulisher
Jul 16, 2025

MBX Biosciences stock maintains Market Outperform rating at JMP - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

why mbx biosciences inc. stock attracts strong analyst attentionBreakout Confirmation Tool - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How MBX Biosciences Inc. stock performs during market volatilityProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MBX Biosciences Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Insiders Rewarded With US$78k Addition To Investment As MBX Biosciences Stock Hits US$359m - 富途牛牛

Jul 10, 2025
pulisher
Jul 02, 2025

MBX Biosciences stock maintains Market Outperform rating at JMP on strong Yorvipath launch - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

MBX Biosciences, Inc.(NasdaqGS: MBX) dropped from Russell 3000 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

MBX Biosciences, Inc.(NasdaqGS: MBX) dropped from Russell 2000 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 24, 2025

Stifel reiterates buy rating on MBX Biosciences stock ahead of trial - Investing.com India

Jun 24, 2025
pulisher
Jun 23, 2025

MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development - GlobeNewswire

Jun 23, 2025
pulisher
Jun 18, 2025

Strategic Growth and Clinical Advancements Propel MBX Biosciences to a Buy Rating - TipRanks

Jun 18, 2025

Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.62
price up icon 3.26%
$36.56
price up icon 1.51%
$103.38
price down icon 0.14%
$27.57
price down icon 1.58%
$114.12
price down icon 0.42%
biotechnology ONC
$296.06
price up icon 0.42%
Kapitalisierung:     |  Volumen (24h):